Since its inception in the late 1990s, corneal cross-linking has grown from an interesting
concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of …

Corneal cross-linking (CXL) has profoundly changed the management of keratoconus and
other ectatic corneal diseases. Introduced in the late 1990s, CXL marked the first effective …

Purpose To compare the efficacy of customized corneal cross-linking (CXL) with standard
CXL. Design Prospective, nonrandomized comparative clinical study. Methods In a …

Purpose To determine whether corneal cross-linking (CXL) with individualized fluence
(“sub400 protocol”) is able to stop keratoconus (KC) progression in ultrathin corneas with 12 …

Purpose: Photoactivated chromophore for keratitis cross-linking (PACK-CXL) is used as an
adjunct therapy to antibiotic medication in infectious keratitis. This experimental study aimed …

Objective: To review the literature on current applications of corneal Collagen Cross-Linking
(CXL). Methods: A review of publications on corneal cross-linking was conducted. This …

Purpose. To report the profile of microbial keratitis occurring after corneal collagen cross‐
linking (CXL) in keratoconus patients. Methods. A retrospective analysis of 2350 patients …

Purpose: To evaluate and compare the safety and efficacy of accelerated (AXL) and
standard corneal cross-linking (CXL) protocols in patients with progressive keratoconus …

Purpose: To evaluate the safety, efficacy, and stability of topography-guided partial PRK
combined with corneal cross-linking (CXL)(the Athens Protocol [AP]) in pediatric patients …

Customized cross-linking has been proposed as an alternative to conventional cross-linking
in patients with progressive keratoconus, targeting greater flattening of the cone region and …